102 related articles for article (PubMed ID: 12536633)
1. [Preliminary study of the gene structure of human glycosylphosphatidylinositol specific phospholipase D].
Tang JH; Gu SL; Zhang XJ
Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):95-7. PubMed ID: 12536633
[TBL] [Abstract][Full Text] [Related]
2. [Competitive RT-PCR assay for quantification of GPI-PLD gene expression].
Zhang XJ; Lu CP; Tang JH
Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):322-6. PubMed ID: 14653107
[TBL] [Abstract][Full Text] [Related]
3. Effect of glycosylphosphatidylinositol specific phospholipase D gene expression levels on complement mediated killing of leukemic cells in patients with chronic myeloid leukemia.
Jian-Hua T; Xiao-Jie Z; Yi-Dan W; Wen-Kai L; Wang-Jiao H; Cheng-Hong W; Gui-Yuan L
Clin Chim Acta; 2005 Sep; 359(1-2):115-24. PubMed ID: 15907827
[TBL] [Abstract][Full Text] [Related]
4. Genetic regulation of mouse glycosylphosphatidylinositol-phospholipase D.
Flores-Borja F; Kieszkievicz J; Church V; Francis-West PH; Schofield J; Rademacher TW; Lund T
Biochimie; 2004; 86(4-5):275-82. PubMed ID: 15194230
[TBL] [Abstract][Full Text] [Related]
5. Important roles of glycosylphosphatidylinositol (GPI)-specific phospholipase D and some GPI-anchored proteins in the pathogenesis of hepatocellular carcinoma.
Tang JH; He WJ; Huang H; Tan CC; Duan Q; Wang KJ; Yuan XY; Zhu XJ
Clin Biochem; 2009 Mar; 42(4-5):400-7. PubMed ID: 19135435
[TBL] [Abstract][Full Text] [Related]
6. Anti-mouse GPI-PLD antisera highlight structural differences between murine and bovine GPI-PLDs.
Gregory P; Ziemiecki A; Zürcher G; Brodbeck U; Bütikofer P
Biol Chem; 2003 Dec; 384(12):1575-82. PubMed ID: 14719799
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of glycosylphosphatidylinositol (GPI) phospholipase D by suramin-like compounds.
Brunner G; Zalkow L; Burgess E; Rifkin DB; Wilson EL; Gruszecka-Kowalik E; Powis G
Anticancer Res; 1996; 16(5A):2513-6. PubMed ID: 8917344
[TBL] [Abstract][Full Text] [Related]
8. Tolerance of glycosylphosphatidylinositol (GPI)-specific phospholipase D overexpression by Chinese hamster ovary cell mutants with aberrant GPI biosynthesis.
Du X; Cai J; Zhou JZ; Stevens VL; Low MG
Biochem J; 2002 Jan; 361(Pt 1):113-8. PubMed ID: 11742535
[TBL] [Abstract][Full Text] [Related]
9. [Effect of overexpression of glycosylphosphatidylinositol-specific phospholipase D on biological character of hepatocellular carcinoma cell line HepG2].
He WJ; Tang JH; Tan CC; Duan Q; Wang KJ; Zuo KQ; Yuan XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 33(2):103-9. PubMed ID: 18326903
[TBL] [Abstract][Full Text] [Related]
10. A distant evolutionary relationship between GPI-specific phospholipase D and bacterial phosphatidylcholine-preferring phospholipase C.
Rigden DJ
FEBS Lett; 2004 Jul; 569(1-3):229-34. PubMed ID: 15225639
[TBL] [Abstract][Full Text] [Related]
11. An endogenous glycosylphosphatidylinositol-specific phospholipase D releases basic fibroblast growth factor-heparan sulfate proteoglycan complexes from human bone marrow cultures.
Brunner G; Metz CN; Nguyen H; Gabrilove J; Patel SR; Davitz MA; Rifkin DB; Wilson EL
Blood; 1994 Apr; 83(8):2115-25. PubMed ID: 8161780
[TBL] [Abstract][Full Text] [Related]
12. Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D.
Metz CN; Brunner G; Choi-Muira NH; Nguyen H; Gabrilove J; Caras IW; Altszuler N; Rifkin DB; Wilson EL; Davitz MA
EMBO J; 1994 Apr; 13(7):1741-51. PubMed ID: 7512501
[TBL] [Abstract][Full Text] [Related]
13. Midportion antibodies stimulate glycosylphosphatidylinositol-specific phospholipase D activity.
Deeg MA; Bowen RF
Arch Biochem Biophys; 1999 Oct; 370(2):278-84. PubMed ID: 10510287
[TBL] [Abstract][Full Text] [Related]
14. Mutating His29, His125, His133 or His158 abolishes glycosylphosphatidylinositol-specific phospholipase D catalytic activity.
Raikwar NS; Bowen RF; Deeg MA
Biochem J; 2005 Oct; 391(Pt 2):285-9. PubMed ID: 15943582
[TBL] [Abstract][Full Text] [Related]
15. Modification-specific proteomics of plasma membrane proteins: identification and characterization of glycosylphosphatidylinositol-anchored proteins released upon phospholipase D treatment.
Elortza F; Mohammed S; Bunkenborg J; Foster LJ; Nühse TS; Brodbeck U; Peck SC; Jensen ON
J Proteome Res; 2006 Apr; 5(4):935-43. PubMed ID: 16602701
[TBL] [Abstract][Full Text] [Related]
16. [GPI-PLD gene exon14 polymorphisms of leucocyte in peripheral blood from healthy persons and leukemia patients].
Yang ZY; Huang H; Tang JH; Yu H; Wang YD; Xiang XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):28-31. PubMed ID: 16562670
[TBL] [Abstract][Full Text] [Related]
17. Mouse glycosylphosphatidylinositol-specific phospholipase D (Gpld1) characterization.
LeBoeuf RC; Caldwell M; Guo Y; Metz C; Davitz MA; Olson LK; Deeg MA
Mamm Genome; 1998 Sep; 9(9):710-4. PubMed ID: 9716655
[TBL] [Abstract][Full Text] [Related]
18. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism.
Raikwar NS; Cho WK; Bowen RF; Deeg MA
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E463-70. PubMed ID: 16219662
[TBL] [Abstract][Full Text] [Related]
19. [Expression and activity of glycosylphosphatidylinositol-specific phospholipase d mRNA in bone marrow mononuclear cells isolated from patient with acute myeloid leukemia and their significance].
Xiao GF; Tang XY; Li X; Zeng C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):15-8. PubMed ID: 20137110
[TBL] [Abstract][Full Text] [Related]
20. Glycosylphosphatidylinositol-specific phospholipase D immunoreactivity is present in islet amyloid in type 2 diabetes.
Larson DM; Kennedy MA; Bowen RF; Verchere CB; Deeg MA
J Pathol; 2004 Aug; 203(4):961-7. PubMed ID: 15259000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
